At 9.4% CAGR, the Asia Pacific Swine Diagnostics Market is Projected to be worth US$ 132.79 million by 2030, says Business Market Insights

According to Business Market Insights research, the Asia Pacific swine diagnostics market was valued at US$ 64.64 million in 2022 and is expected to reach US$ 132.79 million by 2030, registering a CAGR of 9.4% from 2022 to 2030. Rising demand for pork and pork products and increasing prevalence of swine diseases are the critical factors attributed to the Asia Pacific swine diagnostics market expansion.               

The demand for farm or livestock products has increased globally owing to rising consumer income and population growth. According to the Agricultural 2018–2027 report by the Organization for Economic Co-operation and Development (OECD) and the Food and Agriculture Organization (FAO), a few of the major contributors to global meat production include China and India. The People's Republic of China is the largest meat producer in the world. "Our World in Data 2021" statistics show that approximately 352.13 million ton of meat was produced worldwide in 2021. The swine diagnostics market is expected to benefit from the growing demand for pork in the world. Most of Europe's pork exports go to East Asia, particularly China.  

On the contrary, high costs involved in pork health maintenance hurdles the growth of Asia Pacific industrial robotics market.

Based on product type, the Asia Pacific swine diagnostics market is segmented into immunoassays kits, PCR kits, hemagglutination inhibition (HI), and others. The immunoassays kits segment held 43.9% share of Asia Pacific swine diagnostics market in 2022, amassing US$ 28.41 million. It is projected to garner US$ 61.38 million by 2030 to expand at 10.1% CAGR during 2022–2030.

Based on sample type, the Asia Pacific swine diagnostics market is segmented into blood, oral fluids, nasal swabs, tissue samples, and others. The blood segment held 40.5% share of Asia Pacific swine diagnostics market in 2022, amassing US$ 26.15 million. It is projected to garner US$ 57.31 million by 2030 to expand at 10.3% CAGR during 2022–2030.

Based on disease, the Asia Pacific swine diagnostics market is segmented into African swine fever (ASF)/classical swine fever (CSF), respiratory diseases, porcine circovirus, porcine epidemic diarrhea, swine dysentery, and others. The African swine fever (ASF)/classical swine fever (CSF) segment held 32.8% share of Asia Pacific swine diagnostics market in 2022, amassing US$ 21.19 million. It is projected to garner US$ 44.66 million by 2030 to expand at 9.8% CAGR during 2022–2030.  

Based on end user, the Asia Pacific swine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end users. The veterinary hospitals segment held 61.2% share of Asia Pacific swine diagnostics market in 2022, amassing US$ 39.56 million. It is projected to garner US$ 82.57 million by 2030 to expand at 9.6% CAGR during 2022–2030.

Based on country, the Asia Pacific swine diagnostics market is segmented into China, South Korea, Japan, India, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 62.3% share of Asia Pacific swine diagnostics market in 2022. It was assessed at US$ 40.29 million in 2022 and is likely to hit US$ 83.72 million by 2030, exhibiting a CAGR of 9.6% during 2022–2030.  

Key players operating in the Asia Pacific swine diagnostics market are BioCheck BV, Bionote Inc, Idexx Laboratories Inc, Innovative Diagnostics SAS, Neogen Corp, Ring Biotechnology Co Ltd, SAN Group GmbH, Thermo Fisher Scientific Inc, and Zoetis Inc, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com